ExodusPoint Capital Management LP Raises Stock Holdings in Reneo Pharmaceuticals, Inc.

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
ExodusPoint Capital Management LP raised its position in Reneo Pharmaceuticals, Inc. by 125.9 percent in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 555,316 shares of the companys stock after buying an additional 309,529 shares during the

Read at thelincolnianonline.com
news
  

Reneo Pharmaceuticals Fundamental Analysis

We analyze Reneo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reneo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reneo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Reneo Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Reneo Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Reneo Pharmaceuticals Related Equities

CNSPCns Pharmaceuticals   5.45   
0%
100.0%
PRMEPrime Medicine,   5.07   
0%
93.0%
CGEMCullinan Oncology   3.99   
0%
73.0%
CELCCelcuity LLC   2.79   
0%
51.0%
CCCCC4 Therapeutics   2.58   
0%
47.0%
NKTXNkarta   2.55   
0%
46.0%
KZRKezar Life   2.13   
0%
39.0%
HOWLWerewolf Therapeutics   1.95   
0%
35.0%
RPRXRoyalty Pharma   0.67   
0%
12.0%
ADPTAdaptive Biotechnologies   0.00   
0%
0%
SMMTSummit Therapeutics   0.00   
0%
0%
LEGNLegend Biotech   0.06   
1.0%
0%
HEPAHepion Pharmaceuticals   0.20   
3.0%
0%
VIRVir Biotechnology   0.41   
7.0%
0%
IMMXImmix Biopharma   0.92   
16.0%
0%
DNAGinkgo Bioworks   0.95   
17.0%
0%
APLSApellis Pharmaceuticals   1.11   
20.0%
0%
EWTXEdgewise Therapeutics   1.20   
22.0%
0%
KRONKronos Bio   3.16   
57.0%
0%
OCEAOcean Biomedical   3.22   
59.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Reneo Stock

If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance